Cannabinoid CB1 receptor antagonism markedly increases dopamine receptor-mediated stereotypies.
Ferrer B, Gorriti MA, Palomino A, Gornemann I, de Diego Y, Bermudez-Silva FJ, Bilbao A, Fernandez-Espejo E, Moratalla R, Navarro M, Rodríguez de Fonseca F.
Ferrer B, et al. Among authors: bilbao a.
Eur J Pharmacol. 2007 Mar 22;559(2-3):180-3. doi: 10.1016/j.ejphar.2007.01.009. Epub 2007 Jan 19.
Eur J Pharmacol. 2007.
PMID: 17291487